PubMed Health⌕ Search

PubMed · 8712496

Not all bone loss created equal.

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Y S Eisenberger. 1996. Not all bone loss created equal.. https://doi.org/10.1043/0003-3219(1996)066%3C0085%3Anablce%3E2.3.co%3B2

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Detection of receptor activator of NF-kappa beta ligand in apical periodontitis.

A novel protein known as receptor activator of NF-kappa beta ligand (RANK-L) has been identified as a potential osteoclast differentiation factor. However, comparatively little is known about the expression of RANK-L in the pathogenesis of periradicular lesions. In this study, RANK-L expression was evaluated in biopsy specimens from apical periodontitis. Tissue samples from 21 periapical lesions were collected. RANK-L mRNA was isolated by using the guanidinium isothiocyanate acid phenol method. This was followed by generation of cDNA using specific primer for RANK-L by reverse transcription polymerase chain reaction amplification. RANK-L expression in each periapical sample was assessed by agarose gel electrophoresis. Gel electrophoresis analysis showed a single band of 385 bp corresponding to RANK-L in every periapical lesion. By contrast, normal control tissue showed no detectable RANK-L mRNA expression. In conclusion, RANK-L may play a role in apical periodontitis-induced bone resorption.

Alveolar Bone Loss↗

Effects of bone morphogenetic protein-6 on periodontal wound healing in a fenestration defect of rats.

BACKGROUND: Bone morphogenetic proteins (BMPs) may play significant roles in bone formation. The ability of BMP-6 to promote wound healing has been chosen as the subject of this investigation. In this study, a synthetic rat BMP-6 polypeptide was applied to a periodontal fenestration defect in rats to elucidate the effects of BMP-6 on periodontal wound healing. MATERIAL AND METHODS: Following surgery to create a bony window on the buccal aspects of mandibular molar roots, 24 male Sprague Dawley rats were divided into four groups according to BMP application (0, 1, 3 and 10 microg, respectively). Animals were killed after 28 days and the mandible taken for histological examination. Histometric measurements were performed on sections selected from three levels (coronal, middle and apical levels; with 240 microm apart from the central) of the defect. New bone and cementum formation (including area and thickness) were analyzed and compared. RESULTS: In general, minimal new bone was observed on the surgically created defects in the non-BMP group, whereas a complete osseous healing occurred in all BMP-6 treated animals. New bone formation (both in area and thickness) was significantly influenced by both the dosage and the examining level, whereas new cementum formation was affected by dosage only. An increase in bone and cementum formation was noted in all three BMP groups when compared with the control group at all examined levels. Among the BMP groups, greatest new bone and cementum formation were noted in the 3 microg group. New cementum thickness increased on the cementum surfaces of the defects compared with the dentinal surfaces in all study groups. CONCLUSION: An increase in new bone and cementum formation was noted after applying a synthetic BMP-6 polypeptide to a periodontal fenestration defect in rats. Therefore, we suggest that BMP-6 may play a certain role in periodontal regeneration.

Alveolar Bone Loss↗

Chronic glycine treatment inhibits ligature-induced periodontal disease in Wistar rats.

OBJECTIVE: Dysregulation of immune and stress responses plays a significant role for the development and progression of inflammatory diseases, including periodontal disease. The non-essential amino acid glycine modulates immune and central nervous system (CNS) responses, and has been shown to beneficially affect tissue destructive inflammatory conditions. The purpose of this study was to test the ability of orally administered glycine to influence periodontal disease progression, as well as immune and hypothalamic-pituitary-adrenal (HPA) responses following lipopolysaccharide stimulation. METHODS: Glycine was supplied in the drinking water during the whole experiment to male Wistar rats, starting 3 days before the induction of experimental ligature-induced periodontal disease. Control rats were given tap water only. The periodontal breakdown was assessed after the ligatures had been in place for 34 days. Following intraperitonal lipopolysaccharide stimulation, concentrations of the proximal cytokines tumour necrosis factor-alpha (TNF-alpha) and interleukin-10, as well as the HPA axis-derived hormone corticosterone, were measured in blood serum. RESULTS: Orally administered glycine significantly reduced periodontal bone loss as measured by digital X-rays (p = 0.007). Bone loss was negatively correlated with increased serum glycine, whereas no significant relationship was found with TNF-alpha, interleukin-10, or corticosterone. CONCLUSION: Chronic ingestion of glycine supplied in the drinking water significantly reduced periodontal bone loss. No effect of glycine on immune and HPA-axis responses was revealed. Further studies are needed to clarify the mechanisms of action.

Alveolar Bone Loss↗